NCT01903200View on ClinicalTrials.gov

Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Major Depressive Disorder Patients
Interventions
DRUG

FK949E

Oral

Trial Locations (2)

Unknown

Kansai

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY